MedPath

Role of Yoga on Obstructive Sleep Apnea (OSA)

Phase 2/3
Not yet recruiting
Conditions
OBSTRUCTIVE SLEEP APNEA
Registration Number
CTRI/2018/02/012105
Lead Sponsor
Ministry of AYUSH
Brief Summary

The current study will be a multi-centric, single blinded, parallel group, randomized control trial with four assessment point i.e. Baseline, after 2 weeks, 3 months, 6 months and 12 months. The study will be conducted at two centers i.e. the Dayananda Medical College and Hospital, Ludhiana and Center for Integrative Medicine and Research (CIMR), AIIMS, New Delhi. The participants will be screened and all consenting participants will be recruited from outpatient services of neurology and pulmonary medicine department and from sleep study lab of Dayananda Medical College and Hospital, Ludhiana, after which they will be randomly divided into two groups with an allocation ratio of 1:1. All patients will be assessed for primary and secondary outcomes which include general metabolic measures and inflammatory biomarkers along with neuropsychological measures such as depression, anxiety, memory and QoL at baseline followed by assessments at 2 weeks, 3 months, 6 months and 12 months from baseline. The intervention group will receive the intervention (as defined below) whereas the control will continue to receive standard care at each of the center.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria
  • 1.Patients of all genders and age between 18-70 years.
  • 2.Patients from Delhi NCR for study settings in Delhi.
  • 3.Medical history which is compatible with OSA and AHI more than 15 per hour.
  • 4.Availability of time to include physical activity in their daily routine and to come for the contact classes and investigations as per the protocol.
  • 5.Not been engaged in regular yoga practice or any other alternative medicine for the same desired effect.
Exclusion Criteria
  • 1.Patient’s refusal for Polysomnography.
  • 2.Patients on CPAP.
  • 3.Patients with a well-documented chronic history of congestive heart failure, chronic renal failure or chronic liver failure.
  • 4.Patients having very severe hypoxemia (oxygen saturation <80% for >10% of recording time).
  • 5.Pregnancy 6.Morbid obesity, Hypothyroidism 7.Patients underwent any metabolic surgery 8.Recent trauma to upper respiratory tract 9.Patients on systemic corticosteroid treatment 10.Inability to perform yoga exercises due to orthopaedic or musculoskeletal problems.
  • 11.Patients currently participating in any other clinical trials in the same hospital or any other sites.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Apnoea hypopnea indexBaseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
2.Oxygen desaturation index (ODI)Baseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
3.Heart Rate Variability (HRV)Baseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
Secondary Outcome Measures
NameTimeMethod
Stress and Inflammatory biomarkersBaseline,at 3 months, at 6 months, and at 12 months from baseline
Neuropsychological Evaluation Screening Tool (NEST) and Hindi Mental Status Examination (HMSE)Baseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
Wechsler Memory Scale- III (WMS III) Indian EditionBaseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
The Pittsburgh Sleep Quality Index (PSQI)Baseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
Hamilton’s Depression Questionnaire (HAM-D)Baseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
The Hamilton Anxiety Rating Scale (HAM-A)Baseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
WHO QoL BREF questionnaireBaseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline
General metabolic parametersBaseline, at 2 weeks,at 3 months, at 6 months, and at 12 months from baseline

Trial Locations

Locations (2)

All India Institute of Medical Sciences (AIIMS)

🇮🇳

South, DELHI, India

DAYANAND MEDICAL COLLEGE AND HOSPITAL

🇮🇳

Ludhiana, PUNJAB, India

All India Institute of Medical Sciences (AIIMS)
🇮🇳South, DELHI, India
GAUTAM SHARMA
Principal investigator
01126549326
drsharmagautam@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.